"Right from the start of Wayne's tenure, he has talked about R&D to develop ADAPT into 3D products."
From the investor presentation - 2020 milestones -
From direct inquiry to the Company-
"The first is the use of the technology on Dural Repair (tissue surrounding spinal cord) and second is the use of the technology on hernia (soft tissue) repair."
No mention in the CEO's investor presentation of the Dural Repair or Hernia repair but it does look like there is a bit going on in the background other than DurAVR.
New AVR detailed research report with valuations, page-22
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.20 |
Change
-0.800(5.71%) |
Mkt cap ! $279.0M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.00 | $13.11 | $947.2K | 71.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.35 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |